Advanced Researchers Team @Kovler Diabetes Center

Archive

https://kovlerdiabetescenter.org/portfolio/trialnet-hydroxychloroquine-prevention/ About this Study TrialNet Hydroxychloroquine (HCQ) Prevention is a double-blinded, multicenter, randomized, placebo-controlled trial to determine whether treatment of participants with Stage 1 T1D (2 or more antibodies with normal glucose tolerance) with HCQ results in delay or prevention of progression to Stage 2 T1D (abnormal...

Karen Wu is the Communication Specialist for the Kovler Diabetes Center. She holds a BA in Applied Health Science, majored in Hospital Administration and minored in Communication. Karen is passionate about healthcare communications and raising awareness on health disparities....

Clinical Research Nurse Rabia is a registered nurse and certified diabetes educator who has over 4 years of clinical experience in diabetes.  As a type 1 diabetic herself, Rabia has a great interest in working with the Kovler Diabetes Research team.  Rabia has held previous roles...